The ACI 7000 corneal inlay has shown safety and efficacy over a two-year study period in presbyopia patients, according to a study published in the Journal of Refractive Surgery.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.